Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Archive
  • Info for
    • Authors
    • Subscribers
    • Advertisers
    • Editorial Board
  • Other Publications
    • Anticancer Research
    • In Vivo
  • More
    • IIAR
    • Conferences
  • About Us
    • General Policy
    • Contact
  • Other Publications
    • Cancer Genomics & Proteomics
    • Anticancer Research
    • In Vivo

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Cancer Genomics & Proteomics
  • Other Publications
    • Cancer Genomics & Proteomics
    • Anticancer Research
    • In Vivo
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Cancer Genomics & Proteomics

Advanced Search

  • Home
  • Content
    • Current
    • Archive
  • Info for
    • Authors
    • Subscribers
    • Advertisers
    • Editorial Board
  • Other Publications
    • Anticancer Research
    • In Vivo
  • More
    • IIAR
    • Conferences
  • About Us
    • General Policy
    • Contact
  • Visit iiar on Facebook
  • Follow us on Linkedin
Review ArticleArticles

Comparison of Open-access Databases for Clinical Variant Interpretation in Cancer: A Case Study of MDS/AML

HENRIK BANCK, MARTIN DUGAS, CARSTEN MÜLLER-TIDOW and SARAH SANDMANN
Cancer Genomics & Proteomics March 2021, 18 (2) 157-166; DOI: https://doi.org/10.21873/cgp.20250
HENRIK BANCK
1Institute of Medical Informatics, University of Münster, Münster, Germany;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
MARTIN DUGAS
1Institute of Medical Informatics, University of Münster, Münster, Germany;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
CARSTEN MÜLLER-TIDOW
2Medizinische Klinik, Abteilung Innere Medizin V, University Hospital Heidelberg, Heidelberg, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
SARAH SANDMANN
1Institute of Medical Informatics, University of Münster, Münster, Germany;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: sarah.sandmann@unimuenster.de
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Article Information

vol. 18 no. 2 157-166
DOI 
https://doi.org/10.21873/cgp.20250
PubMed 
33608312

Published By 
International Institute of Anticancer Research
Print ISSN 
1109-6535
Online ISSN 
1790-6245
History 
  • Received December 29, 2020
  • Revision received January 23, 2021
  • Accepted January 29, 2021
  • Published online February 19, 2021.

Copyright & Usage 
Copyright© 2021, International Institute of Anticancer Research (Dr. George J. Delinasios), All rights reserved

Author Information

  1. HENRIK BANCK1,
  2. MARTIN DUGAS1,
  3. CARSTEN MÜLLER-TIDOW2 and
  4. SARAH SANDMANN1⇑
  1. 1Institute of Medical Informatics, University of Münster, Münster, Germany;
  2. 2Medizinische Klinik, Abteilung Innere Medizin V, University Hospital Heidelberg, Heidelberg, Germany
  1. Correspondence to: Sarah Sandmann, Institute of Medical Informatics, University of Münster, Albert-Schweitzer-Campus 1, Building A11, Münster, Germany. E-mail: sarah.sandmann{at}unimuenster.de
View Full Text
Previous
Back to top

In this issue

Cancer Genomics - Proteomics: 18 (2)
Cancer Genomics & Proteomics
Vol. 18, Issue 2
March-April 2021
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
  • Back Matter (PDF)
  • Ed Board (PDF)
  • Front Matter (PDF)
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Cancer Genomics & Proteomics.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Comparison of Open-access Databases for Clinical Variant Interpretation in Cancer: A Case Study of MDS/AML
(Your Name) has sent you a message from Cancer Genomics & Proteomics
(Your Name) thought you would like to see the Cancer Genomics & Proteomics web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
7 + 9 =
Solve this simple math problem and enter the result. E.g. for 1+3, enter 4.
Citation Tools
Comparison of Open-access Databases for Clinical Variant Interpretation in Cancer: A Case Study of MDS/AML
HENRIK BANCK, MARTIN DUGAS, CARSTEN MÜLLER-TIDOW, SARAH SANDMANN
Cancer Genomics & Proteomics Mar 2021, 18 (2) 157-166; DOI: 10.21873/cgp.20250

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Reprints and Permissions
Share
Comparison of Open-access Databases for Clinical Variant Interpretation in Cancer: A Case Study of MDS/AML
HENRIK BANCK, MARTIN DUGAS, CARSTEN MÜLLER-TIDOW, SARAH SANDMANN
Cancer Genomics & Proteomics Mar 2021, 18 (2) 157-166; DOI: 10.21873/cgp.20250
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Materials and Methods
    • Results
    • Discussion
    • Conclusion
    • Acknowledgements
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • PDF

Related Articles

  • No related articles found.
  • PubMed
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

  • Combination Methionine-methylation-axis Blockade: A Novel Approach to Target the Methionine Addiction of Cancer
  • Rare KMT2A-ELL and Novel ZNF56-KMT2A Fusion Genes in Pediatric T-cell Acute Lymphoblastic Leukemia
Show more Articles

Similar Articles

Keywords

  • Variant interpretation
  • mutation databases
  • somatic variants in cancer
Cancer & Genome Proteomics

© 2021 Cancer Genomics & Proteomics

Powered by HighWire